Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 12 | 2019 | 1108 | 1.370 |
Why?
|
| Exercise | 13 | 2019 | 605 | 1.180 |
Why?
|
| Caloric Restriction | 4 | 2019 | 91 | 1.010 |
Why?
|
| Aging | 6 | 2017 | 941 | 0.880 |
Why?
|
| Aged | 32 | 2020 | 10257 | 0.840 |
Why?
|
| Adipose Tissue | 4 | 2011 | 318 | 0.700 |
Why?
|
| Pericardium | 2 | 2011 | 52 | 0.680 |
Why?
|
| Resistance Training | 3 | 2016 | 59 | 0.660 |
Why?
|
| Exercise Therapy | 5 | 2019 | 249 | 0.650 |
Why?
|
| Dietary Proteins | 1 | 2020 | 62 | 0.640 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 96 | 0.620 |
Why?
|
| Body Composition | 6 | 2019 | 327 | 0.580 |
Why?
|
| Abdominal Fat | 3 | 2018 | 39 | 0.570 |
Why?
|
| Life Style | 3 | 2018 | 394 | 0.550 |
Why?
|
| Neural Cell Adhesion Molecule L1 | 1 | 2018 | 2 | 0.550 |
Why?
|
| Scavenger Receptors, Class E | 2 | 2008 | 2 | 0.550 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2018 | 39 | 0.540 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 38 | 0.540 |
Why?
|
| Female | 31 | 2020 | 19954 | 0.530 |
Why?
|
| Inflammation | 3 | 2010 | 500 | 0.530 |
Why?
|
| Postmenopause | 2 | 2011 | 424 | 0.520 |
Why?
|
| Exosomes | 1 | 2018 | 43 | 0.520 |
Why?
|
| Geriatrics | 1 | 2018 | 86 | 0.520 |
Why?
|
| Adiposity | 4 | 2016 | 190 | 0.510 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2018 | 122 | 0.500 |
Why?
|
| Male | 29 | 2020 | 19434 | 0.490 |
Why?
|
| Humans | 36 | 2020 | 32284 | 0.490 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2011 | 1052 | 0.470 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 281 | 0.440 |
Why?
|
| Vascular Diseases | 1 | 2015 | 66 | 0.440 |
Why?
|
| Neurons | 1 | 2018 | 484 | 0.410 |
Why?
|
| Hypertension | 5 | 2017 | 983 | 0.410 |
Why?
|
| Electrocardiography | 1 | 2018 | 624 | 0.390 |
Why?
|
| Middle Aged | 17 | 2019 | 11843 | 0.390 |
Why?
|
| Coronary Circulation | 2 | 2016 | 41 | 0.370 |
Why?
|
| Physical Fitness | 3 | 2010 | 120 | 0.360 |
Why?
|
| Myocardium | 2 | 2016 | 184 | 0.350 |
Why?
|
| Lipoprotein Lipase | 1 | 2011 | 13 | 0.350 |
Why?
|
| Atherosclerosis | 3 | 2015 | 806 | 0.350 |
Why?
|
| Lipoproteins, VLDL | 1 | 2011 | 27 | 0.340 |
Why?
|
| Lipase | 1 | 2011 | 30 | 0.340 |
Why?
|
| Brain | 1 | 2018 | 966 | 0.340 |
Why?
|
| Aged, 80 and over | 10 | 2017 | 3896 | 0.340 |
Why?
|
| C-Reactive Protein | 4 | 2017 | 226 | 0.330 |
Why?
|
| Body Mass Index | 6 | 2019 | 863 | 0.330 |
Why?
|
| Blood Pressure | 3 | 2015 | 866 | 0.330 |
Why?
|
| Exercise Tolerance | 4 | 2019 | 119 | 0.320 |
Why?
|
| Ginkgo biloba | 1 | 2010 | 20 | 0.310 |
Why?
|
| Nitric Oxide | 2 | 2009 | 119 | 0.310 |
Why?
|
| Nitrites | 1 | 2009 | 22 | 0.300 |
Why?
|
| Nitrates | 1 | 2009 | 29 | 0.300 |
Why?
|
| Plant Extracts | 1 | 2010 | 61 | 0.300 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 247 | 0.300 |
Why?
|
| Lipoproteins, LDL | 1 | 2009 | 83 | 0.290 |
Why?
|
| Aorta | 1 | 2009 | 120 | 0.280 |
Why?
|
| Comorbidity | 1 | 2009 | 563 | 0.250 |
Why?
|
| Logistic Models | 3 | 2018 | 743 | 0.250 |
Why?
|
| Heart Failure | 3 | 2018 | 727 | 0.220 |
Why?
|
| Interleukin-6 | 3 | 2012 | 222 | 0.220 |
Why?
|
| Sex Factors | 2 | 2017 | 656 | 0.210 |
Why?
|
| Exercise Test | 4 | 2019 | 218 | 0.210 |
Why?
|
| Age Factors | 3 | 2018 | 1179 | 0.180 |
Why?
|
| Gait | 3 | 2017 | 121 | 0.170 |
Why?
|
| North Carolina | 3 | 2015 | 1299 | 0.170 |
Why?
|
| Oxygen Consumption | 4 | 2019 | 140 | 0.170 |
Why?
|
| Polymorphism, Genetic | 2 | 2014 | 179 | 0.170 |
Why?
|
| Cardiovascular Diseases | 3 | 2017 | 1159 | 0.160 |
Why?
|
| Weight Loss | 2 | 2015 | 410 | 0.160 |
Why?
|
| Hand Strength | 2 | 2012 | 98 | 0.160 |
Why?
|
| Proteins | 1 | 2020 | 147 | 0.150 |
Why?
|
| Chronic Disease | 3 | 2010 | 411 | 0.150 |
Why?
|
| Intra-Abdominal Fat | 3 | 2018 | 58 | 0.150 |
Why?
|
| Multivariate Analysis | 2 | 2011 | 650 | 0.140 |
Why?
|
| Risk Factors | 7 | 2017 | 3938 | 0.140 |
Why?
|
| Mobility Limitation | 3 | 2014 | 208 | 0.140 |
Why?
|
| Body Fat Distribution | 1 | 2018 | 25 | 0.140 |
Why?
|
| Sepharose | 1 | 2018 | 6 | 0.140 |
Why?
|
| Biotinylation | 1 | 2018 | 12 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2018 | 1211 | 0.140 |
Why?
|
| Research | 1 | 2018 | 81 | 0.130 |
Why?
|
| Geriatric Assessment | 4 | 2016 | 335 | 0.130 |
Why?
|
| Treatment Outcome | 3 | 2019 | 3410 | 0.130 |
Why?
|
| Cell Separation | 1 | 2018 | 86 | 0.130 |
Why?
|
| Time Factors | 2 | 2015 | 2196 | 0.130 |
Why?
|
| Protein Binding | 1 | 2018 | 243 | 0.130 |
Why?
|
| Disability Evaluation | 2 | 2019 | 241 | 0.130 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 99 | 0.130 |
Why?
|
| Avitaminosis | 1 | 2017 | 2 | 0.130 |
Why?
|
| Vitamin K 1 | 1 | 2017 | 10 | 0.130 |
Why?
|
| Heart | 1 | 2018 | 177 | 0.130 |
Why?
|
| Lysine | 1 | 2017 | 23 | 0.130 |
Why?
|
| Gene Expression | 1 | 2018 | 345 | 0.120 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2016 | 24 | 0.120 |
Why?
|
| European Continental Ancestry Group | 2 | 2017 | 1076 | 0.110 |
Why?
|
| African Continental Ancestry Group | 1 | 2017 | 338 | 0.110 |
Why?
|
| Elasticity | 1 | 2015 | 41 | 0.110 |
Why?
|
| Dobutamine | 1 | 2016 | 54 | 0.110 |
Why?
|
| Continental Population Groups | 1 | 2017 | 228 | 0.110 |
Why?
|
| Ankle Brachial Index | 1 | 2015 | 38 | 0.110 |
Why?
|
| Waist Circumference | 1 | 2015 | 91 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2016 | 146 | 0.110 |
Why?
|
| Forecasting | 1 | 2015 | 144 | 0.110 |
Why?
|
| Stroke Volume | 1 | 2018 | 417 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2017 | 181 | 0.110 |
Why?
|
| Heart Rate | 1 | 2017 | 364 | 0.110 |
Why?
|
| Single-Blind Method | 2 | 2012 | 192 | 0.100 |
Why?
|
| Forced Expiratory Volume | 1 | 2014 | 81 | 0.100 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 34 | 0.100 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 520 | 0.100 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 550 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2015 | 554 | 0.100 |
Why?
|
| Triglycerides | 2 | 2011 | 234 | 0.100 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2014 | 129 | 0.090 |
Why?
|
| Activities of Daily Living | 2 | 2014 | 246 | 0.090 |
Why?
|
| Gene Frequency | 2 | 2014 | 212 | 0.090 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2012 | 8 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 76 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2018 | 858 | 0.090 |
Why?
|
| Perfusion | 1 | 2011 | 75 | 0.090 |
Why?
|
| DNA Primers | 1 | 2011 | 85 | 0.090 |
Why?
|
| Linear Models | 2 | 2010 | 426 | 0.090 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 146 | 0.080 |
Why?
|
| Base Sequence | 1 | 2011 | 256 | 0.080 |
Why?
|
| Genotype | 2 | 2014 | 706 | 0.080 |
Why?
|
| Hemodynamics | 1 | 2011 | 164 | 0.080 |
Why?
|
| Aortic Diseases | 1 | 2011 | 59 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2011 | 81 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2009 | 241 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2015 | 2320 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2011 | 226 | 0.080 |
Why?
|
| Risk Assessment | 1 | 2015 | 1424 | 0.080 |
Why?
|
| Plethysmography | 1 | 2009 | 18 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2018 | 1436 | 0.080 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2009 | 10 | 0.070 |
Why?
|
| Multienzyme Complexes | 1 | 2009 | 19 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 2238 | 0.070 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 77 | 0.070 |
Why?
|
| Absorptiometry, Photon | 2 | 2019 | 98 | 0.070 |
Why?
|
| Probability | 1 | 2009 | 154 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2010 | 566 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2010 | 187 | 0.070 |
Why?
|
| Cohort Studies | 2 | 2011 | 1840 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 212 | 0.070 |
Why?
|
| Exons | 1 | 2008 | 52 | 0.070 |
Why?
|
| Thinness | 1 | 2008 | 32 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 213 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2008 | 90 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2009 | 116 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 555 | 0.060 |
Why?
|
| Lipids | 1 | 2009 | 250 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 1485 | 0.060 |
Why?
|
| Kidney | 1 | 2010 | 520 | 0.060 |
Why?
|
| Incidence | 1 | 2010 | 1244 | 0.060 |
Why?
|
| Overweight | 1 | 2008 | 252 | 0.060 |
Why?
|
| Body Weight | 1 | 2008 | 323 | 0.060 |
Why?
|
| Subcutaneous Fat, Abdominal | 2 | 2018 | 12 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2016 | 3612 | 0.060 |
Why?
|
| Adult | 2 | 2011 | 9263 | 0.040 |
Why?
|
| Antihypertensive Agents | 2 | 2017 | 364 | 0.040 |
Why?
|
| Health Education | 2 | 2014 | 149 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 93 | 0.040 |
Why?
|
| Executive Function | 1 | 2019 | 52 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 80 | 0.040 |
Why?
|
| Thigh | 1 | 2018 | 35 | 0.030 |
Why?
|
| Neuropsychological Tests | 1 | 2019 | 327 | 0.030 |
Why?
|
| Muscle Strength | 1 | 2018 | 136 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 48 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2017 | 38 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2019 | 484 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 98 | 0.030 |
Why?
|
| Calcinosis | 1 | 2017 | 142 | 0.030 |
Why?
|
| Echocardiography, Stress | 1 | 2016 | 23 | 0.030 |
Why?
|
| Coronary Stenosis | 1 | 2016 | 28 | 0.030 |
Why?
|
| Microcirculation | 1 | 2016 | 66 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 53 | 0.030 |
Why?
|
| Cognition | 1 | 2019 | 548 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2017 | 773 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2016 | 153 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2016 | 232 | 0.030 |
Why?
|
| Spirometry | 1 | 2014 | 25 | 0.030 |
Why?
|
| Brachial Artery | 1 | 2014 | 73 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 466 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 72 | 0.020 |
Why?
|
| Stroke | 1 | 2017 | 691 | 0.020 |
Why?
|
| Dinoprost | 1 | 2009 | 10 | 0.020 |
Why?
|
| Nitrogen Oxides | 1 | 2009 | 6 | 0.020 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2009 | 33 | 0.020 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 48 | 0.020 |
Why?
|
| Antioxidants | 1 | 2009 | 119 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2009 | 470 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2009 | 170 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2010 | 548 | 0.020 |
Why?
|
| United States | 1 | 2015 | 4079 | 0.020 |
Why?
|
| Health Status | 1 | 2008 | 356 | 0.020 |
Why?
|
| Animals | 1 | 2010 | 8165 | 0.010 |
Why?
|